ATLAS / Macro Radar / Reporting / FDMT

4D Molecular Therapeutics, Inc. (FDMT) reporting calendar

4D Molecular Therapeutics, Inc. files periodic reports with the SEC as FDMT on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 30 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open FDMT market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-211939
10-K31 Dec 202518 Mar 202677 days0001193125-26-114075
10-Q30 Sep 202510 Nov 202541 days0001193125-25-273343
10-Q30 Jun 202511 Aug 202542 days0000950170-25-106244
10-Q31 Mar 20258 May 202538 days0000950170-25-067040
10-K31 Dec 202428 Feb 202559 days0000950170-25-030056
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126370
10-Q30 Jun 20248 Aug 202439 days0000950170-24-094010
10-Q31 Mar 20249 May 202439 days0000950170-24-056933
10-K31 Dec 202329 Feb 202460 days0000950170-24-023183
10-Q30 Sep 20239 Nov 202340 days0000950170-23-062103
10-Q30 Jun 20239 Aug 202340 days0000950170-23-040661
10-Q31 Mar 202311 May 202341 days0000950170-23-020703
10-K31 Dec 202215 Mar 202374 days0000950170-23-008142
10-Q30 Sep 20228 Nov 202239 days0000950170-22-023185
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016882
10-Q31 Mar 202212 May 202242 days0000950170-22-009702
10-K31 Dec 202128 Mar 202287 days0000950170-22-004794
10-Q30 Sep 202110 Nov 202141 days0000950170-21-004086
10-Q30 Jun 202112 Aug 202143 days0001564590-21-043998
10-Q31 Mar 202113 May 202143 days0001564590-21-027576
10-K31 Dec 202025 Mar 202184 days0001564590-21-015502

Source: SEC EDGAR company submissions for CIK 0001650648. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.